IDT Biologika Establishes New Corporation in the United States
03-Jun-2009
- USA
According to Dr. Ralf Pfirmann, CEO of IDT Biologika, the establishment of operations in the United States will allow the company to support its customers´ operations in the important U.S. drug market and to develop closer working relationships with firms in the region.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.